Primary Mediastinal Large B-cell Lymphoma (PMBCL): Multicenter Retrospective Study
- Conditions
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
- First Posted Date
- 2021-12-17
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 633
- Registration Number
- NCT05162170
- Locations
- 🇮🇹
Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico, Avellino, Italy
🇮🇹U.F. Oncoematologia, IOM (Istituto Oncologico del Mediterraneo), Viagrande, Catania, Italy
🇮🇹SC Ematologia, A.O. SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
Circulating Tumor DNA Genotyping for Biological Monitoring of Patients Treated in the FIL-Rouge Clinical Trial
- Conditions
- Hodgkin Lymphoma
- First Posted Date
- 2021-10-04
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 100
- Registration Number
- NCT05066555
- Locations
- 🇮🇹
Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico, Avellino, Italy
🇮🇹IRCCS Istituto Tumori Giovanni Paolo II - U.O.C Ematologia, Bari, Italy
🇮🇹ASST Spedali Civili di Brescia - Ematologia, Brescia, Italy
Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma
- Conditions
- Follicular Lymphoma
- First Posted Date
- 2021-09-27
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 602
- Registration Number
- NCT05058404
- Locations
- 🇮🇹
IRCCS Istituto Romagnolo per lo studio dei Tumori "Dino Amadori" - IRST S.R.L. - Ematologia, Meldola, Forlì - Cesena, Italy
🇮🇹Nuovo Ospedale Civile di Sassuolo - Day Hospital Oncologico, Sassuolo, Modena, Italy
🇮🇹Ospedale "Monsignor Raffaele Dimiccoli" - Ematologia, Barletta, Barletta Andria Trani, Italy
Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.
- Conditions
- Plasmablastic Lymphoma
- Interventions
- First Posted Date
- 2021-06-07
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 28
- Registration Number
- NCT04915248
- Locations
- 🇮🇹
A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di Ancona, Ancona, Italy
🇮🇹Aviano - IRCCS Centro di Riferimento Oncologico di Aviano - Divisione di Oncologia e dei Tumori immuto-correlati, Aviano, Italy
🇮🇹A.O. Spedali Civili di Brescia - Ematologia, Brescia, Italy
Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.
- Conditions
- Mantle Cell Lymphoma
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2025-01-01
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 80
- Registration Number
- NCT04882475
- Locations
- 🇮🇹
ASST Grande Ospedale Metropolitano Niguarda, Milano, MI, Italy
🇮🇹P.O. Spirito Santo di Pescara - UOS Dipartimentale - Centro di diagnosi e Terapia dei linfomi, Pescara, PE, Italy
🇮🇹AOU Senese - U.O.C. Ematologia, Siena, SI, Italy
The Role of 18F-FDG-PET for Staging and Prognostication
- Conditions
- Mantle Cell Lymphoma
- First Posted Date
- 2020-10-23
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 200
- Registration Number
- NCT04600804
- Locations
- 🇮🇹
Ematologia Ospedale Maggiore Policlinico - Fondazione IRCCS Ca Granda, Milano, Lombardia, Italy
🇮🇹Unità Linfomi - Dipartimento Oncoematologia - Istituto Scientifico San Raffaele, Milano, Milan, Italy
🇮🇹U.O. Ematologia AOU Integrata di Verona, Verona, Veneto, Italy
Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy
- Conditions
- Diffuse Large B-Cell LymphomaElderly Patients
- Interventions
- Drug: Vitamin D3 (Cholecalciferol)Drug: RCHOP o R-miniCHOP at standard doses
- First Posted Date
- 2020-06-22
- Last Posted Date
- 2022-08-26
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 430
- Registration Number
- NCT04442412
- Locations
- 🇮🇹
Matera - Ospedale Madonna delle Grazie - Ematologia, Matera, Italy
🇮🇹Ascoli Piceno - Ospedale C.e G. Mazzoni - U.O.C. di Ematologia, Ascoli Piceno, Italy
🇮🇹Ospedale Oncologico regionale CROB, Rionero in Vulture, Piacenza, Italy
Copanlisib With Rituximab-Bendamustine in Patients With Relapsed-Refractory Diffuse Large B-cell Lymphoma
- First Posted Date
- 2020-06-16
- Last Posted Date
- 2025-01-01
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 37
- Registration Number
- NCT04433182
- Locations
- 🇮🇹
Azienda Ospedaliera Sant'Andrea - Ematologia, Roma, Italy
🇮🇹Centro Riferimento Oncologico - S.O.C. Oncologia Medica A, Aviano, Pordenone, Italy
🇮🇹I.R.C.C.S. Istituto Oncologico Veneto - Oncologia 1, Padova, Italy
Daratumumab Plus Gemcitabine, Dexamethasone, Cisplatin in pt R/R CD38+ PTCL-NOS, AITL and TFH
- Conditions
- Relapsed T-Cell LymphomaRefractory T-Cell Lymphoma
- Interventions
- First Posted Date
- 2020-01-31
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 8
- Registration Number
- NCT04251065
- Locations
- 🇮🇹
Trieste - Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - SC Ematologia, Trieste, Italy
🇮🇹Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) - Ematologia, Meldola, Italy
🇮🇹ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia, Milano, Italy
Carfilzomib + Lenalidomide and Dexamethasone for BTK Inhibitors Relapsed-refractory or Intolerant MCL
- Conditions
- Mantle Cell Lymphoma
- Interventions
- First Posted Date
- 2019-03-27
- Last Posted Date
- 2022-09-15
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 16
- Registration Number
- NCT03891355
- Locations
- 🇮🇹
AOU Senese - U.O.C. Ematologia, Siena, Italy
🇮🇹A.O.U. Citta della Salute e della Scienza di Torino - Ematologia Universitaria, Torino, Italy
🇮🇹Azienda sanitaria-universitaria integrata Trieste (ASUITS) - SC Ematologia, Trieste, Italy